Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2017-10-30

Clinical Trial Update: On Label, Randomized, Double-Blind, Placebo-Controlled Trial of Preoperative Finasteride in Patients Undergoing Transurethral Resection of the Prostate (TURP) [Phase 3]

View source ↗

Summary

This Phase 3 randomized, double-blind, placebo-controlled trial of preoperative finasteride in men undergoing TURP for benign prostatic hyperplasia was withdraw…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • FINASTERIDE (FINASTERIDE)

Snippet

Sponsor: University of Alberta | Conditions: Benign Prostatic Hyperplasia | Phase 3 | Status: WITHDRAWN